EcoDrugPlus

Ensembl ID : ENSOMYG00000047319
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSOMYG00000047804
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSOMYG00000044878
Gene Symbol: -
Cross references: -
127 Possible Orthologues:

Ensembl ID : ENSOMYG00000049241
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSOMYG00000049274
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSOMYG00000044811
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSOMYG00000049994
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSOMYG00000051393
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSOMYG00000052035
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSOMYG00000052090
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSOMYG00000044593
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000052768
Gene Symbol: -
Cross references: -
181 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).